Given that KMT2D is a histone methyltransferase that plays a key role in regulating chromatin status and gene expression, we speculated that MI-503 could inhibit KMT2D and play a potential therapeutic role in PCa. The gene discussed is KMT2D; the disease is posterior cortical atrophy.